TP53 and essential hypertension, genetic: Thus, p53 activity does not appear to be necessary for reduced contractility, cardiomyocyte cytotoxicity, or cellular hypertrophy in our MYH7 E848G HCM EHT model, and specific targeting of p53 does not restore the healthy phenotype.